Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion
Kimberly-Clark will buy Kenvue for cash and stock.
Kimberly-Clark to acquire Kenvue in $48.7 billion deal
Kimberly-Clark said on Monday it will acquire Tylenol maker Kenvue in a deal valued at about $48.7 billion.
Earnings Preview: Kenvue (KVUE) Q3 Earnings Expected to Decline
Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Embattled Tylenol Maker Kenvue Hires New Marketing Chief
The company plans to name snack food executive Jon Halvorson as it faces a crisis over concerns of links between Tylenol and autism.
Texas sued Tylenol maker Kenvue, alleging it deceived pregnant women about risks associated with autism
The suit alleges that the Tylenol maker engaged in deceptive marketing by advertising the product as safe to use while pregnant.
Buy 2 Ideal Dividend Kings Of 25 'Safer' In October's 56
This October's Dividend Kings list features 56 stocks, with Kenvue and United Bankshares meeting the ideal "fair price" yield criteria. Analysts project the top-ten Dividend Kings could deliver 19.2% to 41.5% net gains by October 2026, with KVUE offering the highest upside. Only two of the top-ten Kings, KVUE and UBSI, are considered "safer" with sufficient free cash flow to cover their dividends at current prices.
Does Tylenol cause autism? Researchers can use ‘natural experiments' to study the link, write Drs.
In the absence of randomized trials on the effects of acetaminophen, researchers need to use ‘natural experiments' to develop better guidance for patients.
RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next?
Tylenol may be only the beginning.
Attorneys urge court overseeing Tylenol autism lawsuits to consider Trump administration's stance
Families appealing the dismissal of their lawsuits alleging that Kenvue's Tylenol or generic versions of the pain-relief medication caused their children's autism are asking an appeals court to consider President Donald Trump's new advice that pregnant women avoid the pain killer as it decides whether to revive their lawsuits.
RFK Jr.'s team wanted to tout an autism therapy. But a meeting with Tylenol's maker convinced the U.S. health secretary to put the emphasis on acetaminophen
The heads of key health agencies advocated for putting the emphasis on leucovorin, but Kennedy became convinced that he had a moral duty to get the word out about the risk of acetaminophen.
Kenvue: This Too Shall Pass
Kenvue shares have dropped 17% following reports linking Tylenol to autism, creating a potential long-term buying opportunity. The market reaction appears to be an overreaction, as Tylenol accounts for roughly $1 billion in sales and a fraction of Kenvue's total revenue. The current valuation implies an unrealistic 40%+ decline in Tylenol sales, which seems excessive given the actual business impact.
Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism
Kenvue stock is rebounding. It may be a largely a case of things-could've-been- worse.
